MARKET

BRRGF

BRRGF

Oncoinvent ASA
EXMKT
1.770
NaN%
Opening 09:30 06/10 EDT
OPEN
--
PREV CLOSE
0.025
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.500
52 WEEK LOW
1.770
MARKET CAP
7.93M
P/E (TTM)
-0.1426
1D
5D
1M
3M
1Y
5Y
1D
Oncoinvent Aligns Board Incentives with Equity Grants as Radspherin Advances
TipRanks · 05/20 19:02
Oncoinvent Clears AGM Agenda as It Pushes Radspherin Toward Post-Surgical Cancer Market
TipRanks · 05/20 09:35
Oncoinvent Finalizes Major Share Capital Reduction Amid Progress on Cancer Therapy Radspherin
TipRanks · 05/05 08:33
Oncoinvent Advances Radspherin Program With New Patent, Phase 2 Recruitment and CFO Hire
TipRanks · 04/29 05:40
Oncoinvent Sets Virtual AGM as Radspherin Development Advances
TipRanks · 04/28 11:10
Oncoinvent Sets April Webcast as Radspherin Program Gains Momentum
TipRanks · 04/23 05:37
Oncoinvent Publishes 2025 Annual Report as Radspherin Program Advances
TipRanks · 04/22 15:07
Oncoinvent Secures Key Chinese Patent for Lead Radiopharmaceutical Radspherin
TipRanks · 03/19 07:33
More
About BRRGF
Oncoinvent ASA, formerly Bergenbio ASA, is a Norway-based clinical-stage biopharmaceutical company focused on developing drugs for aggressive diseases including cancer and severe respiratory infections. The Company's business portfolio comprises such development stage products as oral axillary lymphoscintigraphy (AXL) which is a tyrosine kinase target that mediates aggressive disease. Under normal healthy physiological conditions, there is low expression of AXL. However, in aggressive diseases, such as cancer and severe respiratory infections, AXL signaling is upregulated in response to hypoxia, inflammation, cellular stress and drug treatment. The Company's flagship product is BGB324, is a selective, potent and orally bio-available small molecule AXL inhibitor in Phase II clinical trials in cancer indications and COVID-19. The Company is based in Bergen, Norway with a subsidiary in Oxford, UK.

Webull offers Oncoinvent ASA stock information, including EXMKT: BRRGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRRGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BRRGF stock methods without spending real money on the virtual paper trading platform.